Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | ERN1 | O75460 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | IKBKB | O14920 | 1/20 | 0.34 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3060234 | 0.80 | GPR3 (0.44) | GPR3ALDH1A1ALOX15HDAC1HDAC8 | |
| SCHEMBL843065 | 0.78 | GPR3 (0.46) | GPR3CYP2A6PADI4ALDH1A1ERN1 | |
| SCHEMBL19225704 | 0.78 | GPR3 (0.46) | GPR3CYP2A6PADI4ALDH1A1ERN1 | |
| SCHEMBL1093585 | 0.76 | GPR3 (0.44) | GPR3CYP2A6PADI4ALDH1A1ERN1 | |
| SCHEMBL1350034 | 0.76 | GPR3 (0.44) | GPR3CYP2A6PADI4ALDH1A1ERN1 | |
| SCHEMBL14709198 | 0.75 | L3MBTL1 (0.41) | GPR3CYP2A6PADI4ALDH1A1MAPT | |
| SCHEMBL5792570 | 0.73 | L3MBTL1 (0.49) | GPR3CYP2A6PADI4ALDH1A1MCL1 | |
| SCHEMBL11900815 | 0.72 | GPR3 (0.44) | GPR3CYP2A6PADI4ALDH1A1ALOX15 | |
| SCHEMBL23303025 | 0.72 | CNR2 (0.46) | GPR3CYP2A6PADI4ALDH1A1 | |
| SCHEMBL10375309 | 0.72 | GPR3 (0.40) | GPR3CYP2A6PADI4ALDH1A1ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114755889-B | Dry film resist and photosensitive dry film | 杭州福斯特电子材料有限公司 | 2024-12-31 | — | — | CN | disclosed |
| US-20220396581-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | Janssen Biopharma, Inc. (US) | 2022-12-15 | — | — | US | disclosed |
| CN-114755889-A | Dry film resist and photosensitive dry film | 杭州福斯特电子材料有限公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-114594656-A | Photosensitive resin composition, photosensitive dry film and corresponding element | 杭州福斯特应用材料股份有限公司 | 2022-06-07 | — | — | CN | disclosed |
| US-11014935-B2 | Compounds for the treatment of paramyxovirus viral infections | Janssen Biopharma, Inc. (US) | 2021-05-25 | — | — | US | disclosed |
| US-20170283429-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | Janssen Biopharma, Inc. | 2017-10-05 | — | — | US | disclosed |
| US-20170283429-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | Janssen Biopharma, Inc. | 2017-10-05 | — | — | US | disclosed |
| US-20170283429-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | Janssen Biopharma, Inc. | 2017-10-05 | — | — | US | disclosed |
| US-9724351-B2 | Compounds for the treatment of paramoxyvirus viral infections | ALIOS BIOPHARMA, INC. (US) | 2017-08-08 | — | — | US | disclosed |
| US-9724351-B2 | Compounds for the treatment of paramoxyvirus viral infections | ALIOS BIOPHARMA, INC. (US) | 2017-08-08 | — | — | US | disclosed |
| WO-2014031784-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS | ALIOS BIOPHARMA, INC. (US) | 2014-02-27 | — | — | WO | disclosed |
| US-8658805-B2 | Fused polyheteroaromatic compound, organic thin film including the compound, and electronic device including the organic thin film | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2014-02-25 | — | — | US | disclosed |
| US-8658805-B2 | Fused polyheteroaromatic compound, organic thin film including the compound, and electronic device including the organic thin film | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2014-02-25 | — | — | US | disclosed |
| US-20130116447-A1 | FUSED POLYHETEROAROMATIC COMPOUND, ORGANIC THIN FILM INCLUDING THE COMPOUND, AND ELECTRONIC DEVICE INCLUDING THE ORGANIC THIN FILM | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-05-09 | — | — | US | disclosed |
| US-20130116447-A1 | FUSED POLYHETEROAROMATIC COMPOUND, ORGANIC THIN FILM INCLUDING THE COMPOUND, AND ELECTRONIC DEVICE INCLUDING THE ORGANIC THIN FILM | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-05-09 | — | — | US | disclosed |
| EP-1871782-B1 | DIPHOSPHINES AND METAL COMPLEXES | UMICORE AG & CO KG (DE) | 2012-02-29 | — | — | EP | disclosed |
| US-7863447-B2 | Diphosphines and metal complexes | UMICORE AG & CO., KG (DE) | 2011-01-04 | — | — | US | disclosed |
| US-20090270622-A1 | Diphosphines and Metal Complexes | UMICORE AG & CO., KG (DE) | 2009-10-29 | — | — | US | disclosed |
| EP-1871782-A2 | DIPHOSPHINES AND METAL COMPLEXES | Umicore AG & Co. KG (DE) | 2008-01-02 | — | — | EP | disclosed |
| WO-2006111535-A2 | DIPHOSPHINES AND METAL COMPLEXES | UMICORE AG & CO. KG (DE) | 2006-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396581-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | MAVS, SARS1, ZC3HAV1 | GPR3 4319/4885CYP2A6 4442/4885PADI4 1664/4885 |
| US-11014935-B2 | Compounds for the treatment of paramyxovirus viral infections | MAVS, SARS1, ZC3HAV1 | GPR3 4319/4885CYP2A6 4442/4885PADI4 1664/4885 |
| US-20170283429-A1 | COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS | MAVS, SARS1, ZC3HAV1 | GPR3 4319/4885CYP2A6 4442/4885PADI4 1664/4885 |
| US-20090270622-A1 | Diphosphines and Metal Complexes | C9, AP3S1, C5 | GPR3 508/4885CYP2A6 1062/4885PADI4 4441/4885 |
| US-20130116447-A1 | FUSED POLYHETEROAROMATIC COMPOUND, ORGANIC THIN FILM INCLUDING THE COMPOUND, AND ELECTRONIC DEVICE INCLUDING THE ORGANIC THIN FILM | EED, TMED7, PRDM7 | GPR3 4330/4885CYP2A6 3104/4885PADI4 4456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.